Amaç: Alt ekstremite venöz sistem yetersizlikleri, toplumda oldukça yaygın görülen, hayat kalitesinde ve iş gücünde ciddi kayıplara neden olan önemli bir hastalıktır. Bu çalışmamızda, kliniğimizde kronik venöz yetmezlik nedeniyle vena safena magnaya (VSM) radyofrekans ablasyon (RFA), endovenöz lazer ablasyon (EVLA) ve N-butil siyanoakrilat embolizasyonu tedavisi uygulanan hastaların sonuçlarının değerlendirilmesi amaçlanmıştır. Gereç ve Yöntemler: Çalışmaya, Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi Kalp ve Damar Cerrahisi Kliniğine Şubat 2015 ve Şubat 2020 tarihleri arasında başvuran, venöz yetmezliği olan semptomatik 150 hasta dâhil edildi. Seksen (%53,3) hasta kadın, 70 (%46,6) hasta erkek idi. Renkli Doppler ultrasonografi (RDUS) ile VSM çapı kadın hastalarda 5 mm, erkek hastalarda ise 5,5 mm üzerinde olan, reflü süresi 4 sn veya daha uzun olan, VSM'si ciddi derecede tortüyöz olmayan bu hastalara, tek taraflı olmak üzere 50 hastaya RFA (Grup 1) (%33,3), 50 hastaya EVLA (Grup 2) (%33,3) ve 50 hastaya siyanoakrilat ile embolizasyon (Grup 3) (%33,3) uygulandı. Bulgular: Operasyon sonrası 1. sene yapılan RDUS incelemede, 143 (%95,3) hastada VSM tam oklüde iken; 7 (%4,66) hastada %40-60 oranında rekanalizasyon tespit edildi. Grup 1'in 5 yıllık takiplerinde, Grup 2 ve Grup 3'e göre VSM oklüzyon oranları daha yüksek bulunmuştur (%94). Grup 3'ün ise 5 yıllık takiplerinde, Grup 1 ve Grup 2'ye göre %45-65 rekanalizasyon tespit edildi. Sonuç: Retrospektif çalışmamızda, endovenöz tedavi seçenekleri arasında RFA uygulanan hastalarda, uzun dönem sonuçlarında yüksek oklüzyon ve yüksek hasta konforu sağlaması nedeniyle safen ven yetmezliklerinin tedavisinde, diğer tedavi seçeneklerine göre güvenle kullanılabileceği kanaatindeyiz.
Anahtar Kelimeler: Endovenöz lazer ablasyon; N-butil siyanoakrilat embolizasyon; radyofrekans ablasyon; vena safena magna; venöz yetmezlik
Objective: Lower extremity venous system insufficiency is an important disease that is quite common in the society and causes serious losses in quality of life and workforce. In this study, we aimed to evaluate the results of patients who received radiofrequency ablation (RFA), endovenous laser ablation (EVLA) and N-butyl cyanoacrylate embolization for chronic venous insufficiency (CVI) to vena saphena magna (VSM) in our clinic. Material and Methods: For the study, 150 symptomatic patients with venous insufficiency who applied to the Cardiovascular Surgery Clinic of Bakırköy Dr. Sadi Konuk Training and Research Hospital between February 2015 and February 2020 were included in the study. 80 (53.3%) patients were female, 70 (46.6%) patients were male. With color Doppler ultrasound, the VSM diameter is 5 mm in female patients and 5.5 mm in male patients, and the reflux duration is 4 seconds or longer, in these patients whose VSM is not severely tortuous, 50 patients were unilateral RFA (Group 1) (33.3%), 50 patients EVLA (Group 2) (33.3%) and 50 patients were embolized with cyanoacrylate (Group 3) (33.3%) was applied. Results: RDUS examination conducted in the 1st year after the operation, while the VSM was completely occluded in 143 (95.3%) patients, recanalization was detected at a rate of 40-60% in 7 (4.66%) patients. In the 5-year follow-up of Group 1, VSM occlusion rates were found to be higher than Group 2 and Group 3 (94%). In the 5-year followup of Group 3, 45-65% recanalization was detected compared to Group 1 and Group 2. Conclusion: In our retrospective study, we believe that it can be used safely in the treatment of saphenous vein insufficiency compared to other treatment options, since it provides high occlusion, and high patient comfort in patients who undergo RFA among the endovenous treatment options.
Keywords: Endovenous laser ablation; N-butyl cyanoacrylate embolization; radiofrequency ablation; vena saphena magna; venous insufficiency
- Callam MJ. Epidemiology of varicose veins. Br J Surg. 1994;81(2):167-73. [Crossref] [PubMed]
- Oliveira RÁ, Mazzucca ACP, Pachito DV, Riera R, Baptista-Silva JCDC. Evidence for varicose vein treatment: an overview of systematic reviews. Sao Paulo Med J. 2018; 136(4):324-32. [Crossref] [PubMed]
- Bozkurt AK. Varis tedavisinde güncelleme [Treatment of varicose veins-update]. Turkiye Klinikleri J Cosm Dermatol-Special Topics. 2013;6(2):55-8. [Link]
- Doganci S, Demirkilic U. Comparison of 980 nm laser and bare-tip fibre with 1470 nm laser and radial fibre in the treatment of great saphenous vein varicosities: a prospective randomised clinical trial. Eur J Vasc Endovasc Surg. 2010;40(2):254-9. [Crossref] [PubMed]
- Enzler MA, van den Bos RR. A new gold standard for varicose vein treatment? Eur J Vasc Endovasc Surg. 2010;39(1):97-8. [Crossref] [PubMed]
- Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S, et al. Editor's Choice - Management of chronic venous disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678-737. Erratum in: Eur J Vasc Endovasc Surg. 2020;59(3):495. [PubMed]
- Linfante I, Wakhloo AK. Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization. Stroke. 2007;38(4):1411-7. [Crossref] [PubMed]
- Comerota AJ, Ramelet AA, Jawien A, Nicolaides A. Treatment of chronic venous disease of the lower extremities: what's new in guidelines? Phlebolymphology. 2009;16:313-20. [Link]
- Akçalı Y. Tanım, tarihçe ve epidemiyoloji [Definition, history and epidemiology]. Turkiye Klinikleri J Cardiovasc Surg-Special Topics. 2008;1(3):1-5. [Link]
- Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Cantrell A, et al. Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. Br J Surg. 2014; 101(9):1040-52. [Crossref] [PubMed]
- van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009;49(1):230-9. [Crossref] [PubMed]
- Gale SS, Lee JN, Walsh ME, Wojnarowski DL, Comerota AJ. A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein. J Vasc Surg. 2010;52(3):645-50. [Crossref] [PubMed]
- Lurie F, Creton D, Eklof B, Kabnick LS, Kistner RL, Pichot O, et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg. 2003;38(2): 207-14. [Crossref] [PubMed]
- Akça B, Erdil N, Çolak MC, Dişli OM, Yetiş C, Battaloğlu B. Kronik venöz yetersizliğin aynı seansta büyük safen ven endovenöz radyofrekans ablasyon ve miniflebektomi ile tedavisi [Treatment of chronic venous insufficiency with great saphenous vein endovenous radiofrequency ablation and miniphlebectomy in a single session]. Damar Cer Derg. 2017;26(3):85-90. [Crossref]
- Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98(8):1079-87. [Crossref] [PubMed]
- Rodriguez-Acevedo O, Elstner KE, Martinic K, Ibrahim RI, Tomazini Martins R, Arduini F, Ibrahim N. ClosureFast endovenous radiofrequency ablation for great saphenous vein and small saphenous vein incompetence: Efficacy and anatomical failure patterns. Phlebology. 2019;34(4):266-71. [Crossref]
- Whiteley MS, Shiangoli I, Dos Santos SJ, Dabbs EB, Fernandez-Hart TJ, Holdstock JM. Fifteen year results of radiofrequency ablation, using VNUS closure, for the abolition of truncal venous reflux in patients with varicose veins. Eur J Vasc Endovasc Surg. 2017; 54(3):357-62. [Crossref] [PubMed]
- Almeida JI. Nonthermal ablation for the treatment of varicose veins: The evolving minimally invasive methods for saphenous vein ablation. Endovascular Today. 2011:34-8. [Link]
.: Process List